Correlation Between 90331HPL1 and Neurocrine Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both 90331HPL1 and Neurocrine Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 90331HPL1 and Neurocrine Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between US BANK NATIONAL and Neurocrine Biosciences, you can compare the effects of market volatilities on 90331HPL1 and Neurocrine Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 90331HPL1 with a short position of Neurocrine Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of 90331HPL1 and Neurocrine Biosciences.

Diversification Opportunities for 90331HPL1 and Neurocrine Biosciences

-0.38
  Correlation Coefficient

Very good diversification

The 3 months correlation between 90331HPL1 and Neurocrine is -0.38. Overlapping area represents the amount of risk that can be diversified away by holding US BANK NATIONAL and Neurocrine Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurocrine Biosciences and 90331HPL1 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on US BANK NATIONAL are associated (or correlated) with Neurocrine Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurocrine Biosciences has no effect on the direction of 90331HPL1 i.e., 90331HPL1 and Neurocrine Biosciences go up and down completely randomly.

Pair Corralation between 90331HPL1 and Neurocrine Biosciences

Assuming the 90 days trading horizon US BANK NATIONAL is expected to under-perform the Neurocrine Biosciences. But the bond apears to be less risky and, when comparing its historical volatility, US BANK NATIONAL is 1.51 times less risky than Neurocrine Biosciences. The bond trades about -0.48 of its potential returns per unit of risk. The Neurocrine Biosciences is currently generating about 0.25 of returns per unit of risk over similar time horizon. If you would invest  12,565  in Neurocrine Biosciences on September 23, 2024 and sell it today you would earn a total of  977.00  from holding Neurocrine Biosciences or generate 7.78% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy42.86%
ValuesDaily Returns

US BANK NATIONAL  vs.  Neurocrine Biosciences

 Performance 
       Timeline  
US BANK NATIONAL 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days US BANK NATIONAL has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, 90331HPL1 is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Neurocrine Biosciences 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Neurocrine Biosciences are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent forward indicators, Neurocrine Biosciences showed solid returns over the last few months and may actually be approaching a breakup point.

90331HPL1 and Neurocrine Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with 90331HPL1 and Neurocrine Biosciences

The main advantage of trading using opposite 90331HPL1 and Neurocrine Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 90331HPL1 position performs unexpectedly, Neurocrine Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurocrine Biosciences will offset losses from the drop in Neurocrine Biosciences' long position.
The idea behind US BANK NATIONAL and Neurocrine Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance